The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study

Abstract Background Pituitary adenylate cyclase-activating polypeptide (PACAP), structurally related to vasoactive intestinal peptide (VIP), is one of the important mediators in the pathogenesis of migraine and is known to dilate cranial arteries and induce headache and migraine. Our objective was t...

Повний опис

Бібліографічні деталі

Автори:	Nadja Bredo Rasmussen, Christina Deligianni, Casper Emil Christensen, William Kristian Karlsson, Haidar Muhsen Al-Khazali, Tom Van de Casteele, Charlotte Granhall, Faisal Mohammad Amin, Messoud Ashina
Формат:	Artigo
Мова:	Inglês
Опубліковано:	BMC 2023-05-01
Серія:	The Journal of Headache and Pain
Предмети:	Migraine Pituitary adenylate cyclase-activating polypeptide Migraine disorders Monoclonal antibody Migraine treatment
Онлайн доступ:	https://doi.org/10.1186/s10194-023-01599-w
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!